NCT05168046

Brief Summary

Mindfulness meditation is an approach that has shown interest in treatment of anxiety in Parkinson's disease. This pilot study aims to assess a more specific effect on tremor using Essential Tremor Embarrassment Assessment and inertial sensors allowing monitoring during sessions and in daily life. This study will focus on 20 patients (10 with and without Mindfulness based intervention and will aim to develop the interface and demonstrate proof of concept before setting up a controlled study

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at P25-P50 for not_applicable parkinson-disease

Timeline
Completed

Started Nov 2021

Typical duration for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2021

Completed
17 days until next milestone

Study Start

First participant enrolled

November 15, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 23, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2024

Completed
Last Updated

September 30, 2025

Status Verified

September 1, 2025

Enrollment Period

2.9 years

First QC Date

October 29, 2021

Last Update Submit

September 24, 2025

Conditions

Keywords

parkinson diseaserest tremormindfulness based interventionsensorsembrassment

Outcome Measures

Primary Outcomes (1)

  • Essential Tremor Embarrassment Assessment score

    Essential Tremor Embarassment Assessment scale, ETEA : this scale is a self questionnaire made up of 14 items (0 to 5, 5 = worst embarrassment)

    Month 6 (M6)

Secondary Outcomes (10)

  • duration of tremor assessed by agenda

    Day 0 (inclusion), Month 3 (M3)

  • duration of tremor assessed by sensors monitoring

    Day 0 (inclusion), Month 3 (M3)

  • feasability of the study : number of patients enrolled

    Month 6 (M6)

  • feasability of the study : number of patients ended the study

    Month 6 (M6)

  • feasability of the study : hours of recording of the tremor

    Month 6 (M6)

  • +5 more secondary outcomes

Study Arms (2)

Parkinson Mindfullness Based Stress Reduction

EXPERIMENTAL

Patients who have an assessment before and after a mindfulness based stress reduction intervention for 6 months

Behavioral: Mindfulness based stress reduction

Parkinson controls

NO INTERVENTION

Patients who have an assessment before and after 6 monthswithout intervention

Interventions

program of weekly mindfulness based stress reduction intervention during 2 months and practice during 3 months

Parkinson Mindfullness Based Stress Reduction

Eligibility Criteria

Age35 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Parkinson disease
  • Hoehn st and yahr stage \<or = 3
  • Age between 35 and 85 years old
  • Treatment stabilized for at least 3 months
  • Disturbing parkinsonian tremor of the upper limb (item MDS -UPDRS 2.10\> 1) and lasting 2 to 6 hours per day
  • patients with internet access

You may not qualify if:

  • Presence of disturbing dyskinetic movements (Item MDS-UPDRS4.2\> 1)
  • Patient who has already practiced meditation in the last 5 years
  • Untreated major depressive episode
  • Hallucinations (Item MDS-UPDRS1.2\> 1))
  • Psychotic disorders - Confusional syndrome
  • presence of signs in favor of an atypical parkinsonian syndrome (oculomotor impairment, early falls, hallucinations, MoCA \<20, early dysautonomia)
  • adult protected by law (guardianship, curatorship or under legal protection)
  • deprivation of liberty by judicial or administrative decision
  • high probability of non-compliance with the protocol or abandonment during the study
  • refusal to sign informed consent
  • Pregnant or breastfeeding woman
  • Lack of social coverage.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montpellier University Hospital

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Parkinson DiseaseTremor

Interventions

Mindfulness-Based Stress Reduction

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesDyskinesiasNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2021

First Posted

December 23, 2021

Study Start

November 15, 2021

Primary Completion

October 20, 2024

Study Completion

October 20, 2024

Last Updated

September 30, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations